Beranda › Leukemia Limfositik Kronis › Montana › Billings
Uji klinis Leukemia Limfositik Kronis di Billings, MT
7 studi untuk Leukemia Limfositik Kronis mencari peserta di lokasi sekitar Billings (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Menerima pesertaFase 3
- Billings Clinic Cancer Center, Billings
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Billings Clinic Cancer Center, Billings
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Menerima pesertaFase 3
- Billings Clinic Cancer Center, Billings
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
Menerima pesertaFase 3
- St Vincent Frontier Cancer Center, Billings
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
Menerima pesertaFase 3
- Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana ( Site 5433), Billings
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Menerima pesertaFase 3
- Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana ( Site 0052), Billings
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Menerima pesertaFase 3
- St. Vincent Frontier Cancer Center, Billings
Uji klinis Leukemia Limfositik Kronis di kota lain
- Boston, MA31 studi
- Columbus, OH28 studi
- Durham, NC27 studi
- Washington, DC22 studi
- Seattle, WA20 studi
- Rochester, MN19 studi
- New York City, NY18 studi
- Houston, TX17 studi
- Baldwin Park, CA16 studi
- Milwaukee, WI15 studi
- Chicago, IL14 studi
- Cincinnati, OH14 studi
Studi lain di Billings
- Kanker Paru Non-Sel Kecil17 studi
- Kanker Prostat15 studi
- Kanker Paru13 studi
- Kanker Payudara10 studi
- Kanker Ovarium9 studi
- Melanoma7 studi
- Kanker Kolorektal6 studi
- Kanker Kolon6 studi
- Kanker Kandung Kemih6 studi
- Leukemia Mieloid Akut6 studi
- Kanker Rektum5 studi
- Kanker Endometrium4 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.